UBS analyst Steven Strycula noted bearish sentiment across U.S. foods has intensified since spring as volumes remain weak among increased competition. He believes Street estimates are too optimistic despite the prospects of tax reform, citing competition, limited vendor pricing amid food cost inflation, rising supply chains costs, and private label substitution risk. Strycula noted shelf space gains are slowing and any increased shelf space has not translated into volume growth. Names in the space include Pinnacle Foods (PF), Nomad Foods (NOMD) and Mondelez (MDLZ).

VP of Kroger, Mary Ellen Adcock, disclosed the sale of 82,806 shares of company stock at $55.61 per share on April 23, for a total transaction amount of $4,605,189.

JPMorgan keeps a Neutral rating on Affirm (AFRM) after CNBC reported that One, a Walmart-backed fintech, has begun offering buy now, pay later at certain U.S. Walmart (WMT) locations. The announcement does not come as a complete surprise, as One first announced it was exploring a BNPL service in December 2022, the analyst tells investors in a research note. The firm points out Affirm expanded its relationship with Walmart in December 2023 to offer BNPL at self-checkout kiosks. For the time being, Affirm will remain a funding option at Walmart but will presumably compete head-to-head with One at the point of sale, adds JPMorgan. It believes the news "highlights the importance, foresight and wisdom" of launching the Affirm Card, which makes Affirm a funding option most anywhere Visa is accepted, while reducing Affirm's reliance on merchant-driven promotion and exclusivity. The firm views the Affirm Card as the company's "ace in the hole."

Attorney General Bob Ferguson announced he signed onto a pending resolution with Kroger that will bring in $47.5M to combat the opioid epidemic in Washington state. Half of these resources will go to the state and the other half will go to Washington city and county governments. The $47.5M will be paid over 11 years. The first payment of $4.3M will come within a few months of the resolution being finalized by the litigating states and local jurisdictions, Ferguson said in a statement.

Mizuho analyst Dan Dolev says Affirm (AFRM) shares are lower today following a report that One, backed by Walmart (WMT), has started offering buy now, pay later loans in-store. However, this is not new news, as this was first reported in December 2022, the analyst tells investors in a research note. The firm says history suggests headline risks for Affirm end up being great buying opportunities. It estimates Walmart accounts for 5% of the company's gross merchandise volume and that all the volume likely won't go away. Affirm's total addressable market is in the trillions, so Walmart supporting buy now, pay later expands the visibility of the category, contends Mizuho. The firm keeps a Buy rating on the stock with a $65 price target.

Walmart's (WMT) majority-owned fintech startup One has begun offering buy now, pay later, or BNPL loans for big-ticket items at some of the retailer's more than 4,600 U.S. stores, putting One in direct competition with Affirm (AFRM), the BNPL leader and exclusive provider of installment loans for Walmart customers since 2019, CNBC's Hugh Son and Melissa Repko reported. Reference Link

JPMorgan analyst Ken Goldman added Albertsons (ACI) to the firm's Analyst Focus List as a value idea and placed the stock on "Positive Catalyst Watch" following the fiscal Q4 earnings release. The "gap between the current share price and fair value is too wide," the analyst tells investors in a research note. The firm says its trimming of out-year estimates does not impair Albertsons' standalone value, which it estimates at $24 per share. JPMorgan continues to believe the stock's valuation discount to Kroger (KR) is too wide given the companies similarities. It also believes the probability that Albertsons gets bought has increased, given yesterday's announcement that additional stores and services will be sent C&S's way. The firm says the risk/reward for Albertsons stock "is becoming too appealing to ignore." It keeps an Overweight rating on the name with a $27 price target.